Results 141 to 150 of about 15,553 (191)

In vitro activity of aztreonam–avibactam combination against blood culture isolates of Stenotrophomonas maltophilia in Japan before the launch of ceftazidime–avibactam

Microbiology Spectrum
Wataru Aoki, Yoshifumi Uwamino, Yuka Kamoshita, Rika Inose, Mika Nagata, Naoki Hasegawa, Hiromichi Matsushita   +6 more
doaj   +1 more source

Cerebrospinal fluid and plasma pharmacokinetics of ceftazidime/avibactam in a neurocritical patient with CRKP intracranial infection and augmented renal clearance. [PDF]

JAC Antimicrob Resist
Huang SM, Chen QH, Wang W, Wang YM, Wei YW, Qu Q, Zhang HN, Qu J.   +7 more
europepmc   +1 more source

Comparative evaluation of disc diffusion and broth microdilution methods for aztreonam/avibactam susceptibility testing in Enterobacterales. [PDF]

J Antimicrob Chemother
Baltas I, Tsakri D, Vourli S, Solanki H, Murrell E, Kiousi E, Tsakris Z, Kuczmar G, Smyrni N, Skiadas I, Grammelis V, Hatcher J, Menegas D, Tsakris A, Vrioni G, Grandjean L.   +15 more
europepmc   +1 more source

Evaluation of high dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation. [PDF]

Int J Clin Pharm
Bauman AJ, Caiazza OG, Wan N, Payer S, Pauly OG, Shoemaker S, Lewis SJ.   +6 more
europepmc   +1 more source

Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-β-lactamase-producing Enterobacterales. [PDF]

Antimicrob Agents Chemother
Castanheira M, Kimbrough JH, Morgan GM, Karr M, Sader HS.   +4 more
europepmc   +1 more source